Hello, Thanks for signing up for MarketBeat Daily Ratings—we’re excited to have you on board. Every weekday, you’ll get a curated summary of new “Buy” and “Sell” ratings from Wall Street’s top-rated analysts, the latest stock news, and bonus investing content—all delivered straight to your inbox. You’re just two quick steps away from completing your sign-up: 1. Make sure our emails go to your inboxGmail users:
Mobile: Tap the three dots (…) in the top right and select Move to Inbox or Move to Primary
Desktop: Click the folder icon at the top and select Move to Inbox or Primary Apple Mail users:
Tap our email address at the top (next to From: on mobile), then select Add to VIP Other providers:
Reply to this message and add newsletters@analystratings.net to your contacts 2. Confirm your subscriptionClick this link to confirm your subscription. This verifies your account and ensures you receive your newsletters without interruption instead of getting stuck in your spam filter. Confirm your subscription here. After you confirm, feel free to download our popular free report, "7 Stocks to Buy and Hold Forever" with this link. Thanks again for subscribing—we look forward to being part of your investing journey. 
Matthew Paulson
Founder and CEO, MarketBeat. P.S. If you didn’t mean to subscribe, no problem—you can unsubscribe here.
Today's Bonus Article
Aeluma's Post-Earnings Dip Creates a Buying OpportunityWritten by Thomas Hughes. Article Posted: 5/15/2026. 
Key Points
- Aeluma's Q3 miss is a non-starter, leaving the outlook unchanged.
- The photonics opportunity is unparalleled, with the potential to disrupt markets.
- With bullish catalysts ahead, the May price pullback is a signal to buy.
- Special Report: Elon Musk already made me a “wealthy man”
Investors looking at Aeluma’s (NASDAQ: ALMU) position in AI and the April stock price increase were given an opportunity by the fiscal Q3 release. Through no fault of its own, the company missed revenue expectations, which were not particularly demanding to begin with. Aeluma is technically a pre-revenue company, with forecast revenue of $1.35 million tied to government contracts. Those contracts were not revoked; rather, they were delayed by government shutdowns that have since been resolved.
The biggest impact on Aeluma has been the delayed start of some projects, but there is no serious impact on its commercialization process. Aeluma Advances Strategy in Q3: That’s What MattersThe company's commercialization process continues to advance. Q3 highlights included new or expanded partnerships with Tower Semiconductor (NASDAQ: TSEM) and Sumitomo Chemical Advanced Technology (OTCMKTS: SOMMY) for wafer production. Sumitomo will apply thin-layer compound semiconductor material to existing semiconductor wafers, then send them to Tower Semiconductor for final manufacturing. Because the compound material is applied directly to the substrate to create a hybrid wafer, the output conforms to standard manufacturing processes, enabling a more streamlined, cost-effective, and time-efficient process. Aeluma is also critical to a number of end markets, including AI, datacenters, autonomous vehicles, industrial applications, and space. While the company is preparing to manufacture a broad range of photonic products, the focus is on quantum dot lasers. Quantum dot lasers offer superior performance, cost, size, and scalability compared with traditional photonic devices and are poised to disrupt the industry. Their main advantages include temperature stability, tolerance, and energy efficiency. Quantum dot lasers function normally at high temperatures, reducing the need for external cooling, tolerate a wider range of defects in the underlying silicon substrate, and use less energy. Aeluma Stumble Triggers Buying OpportunityAmong the risks for investors is the need for capital and the potential for dilution. The company is well-capitalized in 2026, but that came at a cost, and additional capital may be required. As it stands, the company has nearly $38 million in cash, enough to sustain operations, but its share count has increased by more than 36% over the trailing 12 months. The company will likely raise modest amounts through share offerings to fund operational milestones in upcoming quarters, but another significant capital raise is unlikely until 2028. Aside from that, the balance sheet is in good shape, with no long-term debt and minimal liabilities. The impact of the revenue miss and the reduction in guidance on Aeluma’s share price was severe, but traders and investors should take it with a grain of salt. The approximately 35% share price correction that followed earnings was directly related to the strength of the preceding run. ALMU stock advanced by more than 200% in about five weeks and was due for a correction regardless of the news. The critical detail was what came next: a buying signal. 
ALMU’s stock opened with a gap and extended its losses, crossing a critical threshold and triggering a buying frenzy. That threshold is near $23.50, coincident with the top of a trading range and now a strong technical support level. Support is evident on both the weekly and daily charts, as evidenced by candlestick formations and elevated trading volume, suggesting ALMU’s updraft isn’t over just yet. Analyst and institutional data suggest these groups are buying the dip. MarketBeat tracks five analysts with trends showing covering rising, a firm Moderate Buy rating, an 80% buy-side bias, and a steady price target. The price target is interesting because it is around $25, very near the critical support level, and it strengthens the idea that ALMU hit a hard floor with the mid-May price plunge. Institutions, meanwhile, own about 25% of the stock and have been accumulating at a pace of approximately $4-to-$1 since the IPO, sustaining the bullish trend in early Q2 2026. Aeluma Has Catalysts AheadUpcoming catalysts for Aeluma include the company’s improving customer demand profile. The company noted improving demand interest across the spectrum, with AI underpinning the increase. In its view, hyperscalers and enterprises are looking for long-term solutions that Aeluma can provide. Other catalysts include the growing number of patents, now at 36, and the potential for long-term monetization. The patents cover Aeluma’s manufacturing process and design architecture, cementing its role as the source of heterogeneous semiconductor integration and the mass-production techniques critical to the semiconductor supply chain. The biggest risk is adoption. While Aeluma has strong potential and improving end-market demand, no OEM has committed to the product. In this scenario, Aeluma risks another solution taking center stage, limiting its opportunity to do so. However, the likely outcome is that Aeluma continues to advance its capabilities and eventually secures its first major customer. In that scenario, ALMU’s stock price will likely revert to fresh highs. |
Post a Comment
0Comments